While columnist Ben Hofmeister admittedly is no expert on artificial intelligence and healthcare, he thinks it'll be good for MS research.

Enrollment has reached 50% in an ongoing study testing whether a PET tracer can reliably measure myelin damage in people with ...

The two main mouse models used to study myelin damage and repair in MS each replicate certain distinct biological features of ...

CMSC CEO Kathy Costello reflects on the progress made in MS care and what is still needed in the years to come.

Foralumab may help slow disability progression and ease fatigue in people with nonactive SPMS, per data from an early access ...

Columnist Desiree Lama tells the people she loves in a letter that supporting someone with MS isn't about "fixing" them.

For columnist Ahna Crum, spending time in an MRI tube feels like simply another part of living with MS, which requires ...

A study found a twofold higher risk of MS for people with myelitis, or spinal cord inflammation, who have multiple lesions on ...

Cantex and Headlamp Health are teaming up to accelerate the development of azeliragon for severe depression and fatigue in MS ...

A 24-hour Twitch livestream, Dystopia Tonight, will feature TV, music, and comedy entertainers to raise funds for the ...

CAR-M therapy LIB820 may deplete disease-driving B-cells in MS and other autoimmune diseases without severe side effects, new ...

Columnist Lindsay Kelly discusses the importance of recognizing and addressing caregiver burnout before reaching your ...